Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Lambrechts, Diether" or (type exact bookEditor and editor="Lambrechts, Diether")

Add to list
- Journal Article
- A1
- open access
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer : ALEPRO trial

Tine Ottenbourgs, Toon van Gorp, Frédéric Kridelka, Thaïs Baert, Hannelore Denys (UGent) , Frédéric Selle, Inge Baas (UGent) , Anne-Sophie Van Rompuy, Diether Lambrechts and Els Van Nieuwenhuysen

(2024) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 34(4). p.627-630
Add to list
- Miscellaneous
- open access
MultiNicheNet: a flexible framework for differential cell-cell communication analysis from multi-sample multi-condition single-cell transcriptomics data

Robin Browaeys (UGent) , Jeroen Gilis (UGent) , Chananchida Sang-aram (UGent) , Pieter De Bleser (UGent) , Levi Hoste (UGent) , Simon Tavernier (UGent) , Diether Lambrechts, Ruth Seurinck (UGent) and Yvan Saeys (UGent)

(2023)
Add to list
- Journal Article
- A1
- open access
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study

Emiel De Jaeghere (UGent) , Sandra Tuyaerts, An M. T. Van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Lien Lippens (UGent) , Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, et al.

(2023) CANCER IMMUNOLOGY IMMUNOTHERAPY. 72(2). p.475-491
Add to list
- Journal Article
- A1
- open access
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma : an ovarian tumor tissue analysis consortium study

Eun-Young Kang, Ashley Weir, Nicola S Meagher, Kyo Farrington, Gregg S Nelson, Prafull Ghatage, Cheng-Han Lee, Marjorie J Riggan, Adelyn Bolithon, Gordana Popovic, et al.

(2023) CANCER. 129(5). p.697-713
Add to list
- Journal Article
- A1
Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancer

Adriaan Vanderstichele, Liselore Loverix, Pieter Busschaert, Els Van Nieuwenhuysen, Sileny N. Han, Nicole Concin, Tiene Callewaert, Siel Olbrecht, Rawand Salihi (UGent) , Patrick Berteloot, et al.

(2022) GYNECOLOGIC ONCOLOGY. 165(1). p.14-22
Add to list
2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer : the PRIMMO phase II trial

Emiel De Jaeghere (UGent) , Sandra Tuyaerts, Ann M.T. van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, Peter A. van Dam, et al.

(2022) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. In International Journal of Gynecological Cancer 32(Supplement 2). p.A187-A188
Add to list
- Journal Article
- A1
- open access
Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates

Bert Malengier-Devlies, Jessica Filtjens (UGent) , Kourosh Ahmadzadeh, Bram Boeckx, Jessica Vandenhaute, Amber De Visscher, Eline Bernaerts, Tania Mitera, Cato Jacobs, Lore Vanderbeke, et al.

(2022) FRONTIERS IN IMMUNOLOGY. 13.
Add to list
A cellular hierarchy in melanoma uncouples growth and metastasis

Panagiotis Karras, Ignacio Bordeu, Joanna Pozniak, Ada Nowosad, Cecilia Pazzi, Nina Van Raemdonck, Ewout Landeloos, Yannick Van Herck, Dennis Pedri, Greet Bervoets, et al.

(2022) NATURE. 610(7930). p.190-198
Add to list
- Journal Article
- A1
- open access
Polygenic risk modeling for prediction of epithelial ovarian cancer risk

Eileen O. Dareng, Jonathan P. Tyrer, Daniel R. Barnes, Michelle R. Jones, Xin Yang, Katja K. H. Aben, Muriel A. Adank, Simona Agata, Irene L. Andrulis, Hoda Anton-Culver, et al.

(2022) EUROPEAN JOURNAL OF HUMAN GENETICS. 30(3). p.349-362
Add to list
IL1 beta promotes immune suppression in the tumor microenvironment independent of the inflammasome and gasdermin D

Mate Kiss, Lieselotte Vande Walle (UGent) , Pedro Henrique Viana Saavedra (UGent) , Els Lebegge, Helena Van Damme, Aleksandar Murgaski, Junbin Qian, Manuel Ehling, Samantha Pretto, Evangelia Bolli, et al.

(2021) CANCER IMMUNOLOGY RESEARCH. 9(3). p.309-323

Academic Bibliography

A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer : ALEPRO trial

MultiNicheNet: a flexible framework for differential cell-cell communication analysis from multi-sample multi-condition single-cell transcriptomics data

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study

CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma : an ovarian tumor tissue analysis consortium study

Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancer

2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer : the PRIMMO phase II trial

Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates

A cellular hierarchy in melanoma uncouples growth and metastasis

Polygenic risk modeling for prediction of epithelial ovarian cancer risk

IL1 beta promotes immune suppression in the tumor microenvironment independent of the inflammasome and gasdermin D

Contents

Support

Contact